Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolay Borisov

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Entropy (Basel, Switzerland)|January 21, 2023
Asymmetric Adaptive LDPC-Based Information Reconciliation for Industrial Quantum Key DistributionNikolay Borisov, Ivan Petrov, Andrey Tayduganov
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2019
Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer DrugsMarianna Zolotovskaia, Maxim Sorokin, Andrew Garazha, et al.
Frontiers in Digital Health|November 19, 2021
Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize PerformanceQuentin Haas, Nikolay Borisov, David Vicente Alvarez, et al.
Molecular Systems Biology|April 10, 2009
Systems-level interactions between insulin-EGF networks amplify mitogenic signalingNikolay Borisov, Edita Aksamitiene, Anatoly Kiyatkin, et al.
Nature Communications|November 17, 2016
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker developmentIvan V Ozerov, Ksenia V Lezhnina, Evgeny Izumchenko, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Entropy (Basel, Switzerland)|January 21, 2023
Asymmetric Adaptive LDPC-Based Information Reconciliation for Industrial Quantum Key DistributionNikolay Borisov, Ivan Petrov, Andrey Tayduganov
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2019
Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer DrugsMarianna Zolotovskaia, Maxim Sorokin, Andrew Garazha, et al.
Frontiers in Digital Health|November 19, 2021
Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize PerformanceQuentin Haas, Nikolay Borisov, David Vicente Alvarez, et al.
Molecular Systems Biology|April 10, 2009
Systems-level interactions between insulin-EGF networks amplify mitogenic signalingNikolay Borisov, Edita Aksamitiene, Anatoly Kiyatkin, et al.
Nature Communications|November 17, 2016
In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker developmentIvan V Ozerov, Ksenia V Lezhnina, Evgeny Izumchenko, et al.
Pageof 1